Multiple sclerosis and Chemotherapy

Summary:

Chemotherapy is found among people with Multiple sclerosis, especially for people who are female, 40-49 old.

The study analyzes which people have Chemotherapy with Multiple sclerosis. It is created by eHealthMe based on reports of 74 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,086 drugs and 1,364 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Chemotherapy?

Chemotherapy is found to be associated with 223 drugs and 470 conditions by eHealthMe. Check the latest studies of Chemotherapy.



On Aug, 07, 2026

74 people who have Multiple Sclerosis and Chemotherapy are studied.

Would you have Chemotherapy when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Chemotherapy *:

  • female: 87.32 %
  • male: 12.68 %

Age of people who have Multiple Sclerosis and experienced Chemotherapy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 7.14 %
  • 30-39: 17.86 %
  • 40-49: 32.14 %
  • 50-59: 28.57 %
  • 60+: 14.29 %

Common co-existing conditions for these people *:

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 2.70%
  2. Pain: 1 person, 1.35%
  3. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 1 person, 1.35%
  4. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 1 person, 1.35%
  5. Leukaemia (blood or bone marrow cancer): 1 person, 1.35%
  6. Infection: 1 person, 1.35%
  7. High Blood Pressure: 1 person, 1.35%
  8. Depression: 1 person, 1.35%
  9. Back Pain: 1 person, 1.35%

Common drugs taken by these people *:

  1. Avonex: 19 people, 25.68%
  2. Tysabri: 14 people, 18.92%
  3. Rebif: 11 people, 14.86%
  4. Tecfidera: 10 people, 13.51%
  5. Aubagio: 7 people, 9.46%
  6. Copaxone: 6 people, 8.11%
  7. Ampyra: 6 people, 8.11%
  8. Xanax: 3 people, 4.05%
  9. Mavenclad: 3 people, 4.05%
  10. Tracleer: 2 people, 2.70%

Common symptoms for these people *:

  1. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 9.46%
  2. Influenza Like Illness: 6 people, 8.11%
  3. Renal Function Test Abnormal: 3 people, 4.05%
  4. Kidney Stones: 3 people, 4.05%
  5. Fatigue (feeling of tiredness): 3 people, 4.05%
  6. Gait Disturbance: 3 people, 4.05%
  7. Hepatic Adenoma (benign liver tumour): 2 people, 2.70%
  8. Memory Loss: 2 people, 2.70%
  9. Insomnia (sleeplessness): 2 people, 2.70%
  10. Injection Site Reaction: 2 people, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Chemotherapy?

- Check whether Chemotherapy is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Chemotherapy:

All the conditions that are associated with Chemotherapy:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Chemotherapy and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: